Details for Patent: 7,541,363
✉ Email this page to a colleague
Which drugs does patent 7,541,363 protect, and when does it expire?
Patent 7,541,363 protects NOURIANZ and is included in one NDA.
This patent has fourteen patent family members in nine countries.
Summary for Patent: 7,541,363
| Title: | Microcrystal |
| Abstract: | Microcrystals of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,- 6-dione having an average particle size of less than 50 .mu.m; microcrystals of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,- 6-dione having an average particle size of less than 50 .mu.m and a crystallinity of 20% or more or the like, which possess excellent solubility, stability, bioavailability, dispersing property in a pharmaceutical formulation; and the like are provided. A solid pharmaceutical formulation which is characterized by comprising the same is also provided. |
| Inventor(s): | Kuroda; Kazutoshi (Ichikawa, JP), Aoki; Noboru (Numazu, JP), Ochiai; Toshiro (Sunto-gun, JP), Uchida; Akihiro (Sunto-gun, JP), Ishikawa; Yasuhiro (Sunto-gun, JP), Kigoshi; Makoto (Sunto-gun, JP), Hayakawa; Eiji (Sunto-gun, JP), Asanome; Kazuki (Sunto-gun, JP) |
| Assignee: | Kyowa Hakko Kirin Co., Ltd. (Tokyo, JP) |
| Application Number: | 10/554,511 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Device; |
Drugs Protected by US Patent 7,541,363
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-001 | Aug 27, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| Kyowa Kirin | NOURIANZ | istradefylline | TABLET;ORAL | 022075-002 | Aug 27, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,541,363
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2003-131417 | May 9, 2003 |
| PCT Information | |||
| PCT Filed | May 07, 2004 | PCT Application Number: | PCT/JP2004/006495 |
| PCT Publication Date: | November 18, 2004 | PCT Publication Number: | WO2004/099207 |
International Family Members for US Patent 7,541,363
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 546450 | ⤷ Try a Trial | |||
| Australia | 2004236101 | ⤷ Try a Trial | |||
| Canada | 2525037 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
